Journey Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022
Company to host conference call to discuss financial results and provide a corporate update on…
Month: November 2022
Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid
NEW YORK, NY, Nov. 03, 2022 (GLOBE NEWSWIRE) — Love Pharma Inc. (CSE: LUV) (FSE:…
Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems
Remi Robotic Navigation System Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software…
Vesting of restricted share units
November 3, 2022 – announcement no. 10 Chr. Hansen Holding A/S has received notification pursuant…
Healthy Extracts Introduces New Video Series Hosted by Fitness & Nutrition Expert, Whitney Johns, and America’s Healthy Heart Doc, Joel Kahn
First Episode Discusses Natural Ways to Improve Cardiovascular & Sexual Health with the ‘Miracle Molecule,’…
Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing
– Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European…
Albireo Announces 2022 SPARK Grant Winners
— Eight projects selected for inaugural year of the program — Projects provide solutions to…
Phathom Pharmaceuticals to Participate in Upcoming Investor Healthcare Conferences
FLORHAM PARK, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
Pooled Data from the Pivotal Phase 3 VANISH Program Published in the Journal of Women’s Health Demonstrate Significant Efficacy of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
Clinical cure rates, in the pooled analysis, were statistically significantly greater for ibrexafungerp when compared…
Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022
CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Vaxcyte to Present at Upcoming Investor Conferences
SAN CARLOS, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
Shattuck Labs Announces Participation in Upcoming November Conferences
AUSTIN, TX and DURHAM, NC, Nov. 03, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Timber Pharmaceuticals Announces Halt of Common Stock Trading
Compliance with NYSE Listing Requirements Contingent on Stockholder Approval of Reverse Stock Split at Special…
Akoya to Participate at Three Upcoming Investor Conferences
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Aeterna Zentaris Reports Third Quarter 2022 Financial Results
– Company ended the quarter with $53.8 million in cash – Driving continued progress across…
aTyr Pharma to Webcast Conference Call Reporting Third Quarter 2022 Financial Results
Management to host conference call and webcast on November 10th at 5:00 pm EST /…
IO Biotech Announces New Clinical Collaboration with Merck to Evaluate Neoadjuvant and Adjuvant IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) in a Phase 2, Multi-cohort Trial in Patients with Resectable Tumors
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10
Company to host an investor conference call and webcast at 4:30pm ET on that day…
Galecto to Participate in Jefferies London Healthcare Conference
BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…